Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

When interest rates are low, small-cap stocks begin to shine and outpace larger companies in value. These stocks are stocks with a market capitalization between $300 million and $3 billion. These ...

Large-cap stocks are stocks issued by corporations that have major influence over the economy. The “cap” in large-cap refers to the company’s “market capitalization,” which is equal to the company’s ...

Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated history of working in both institutional and retail environments, from broker-dealers to ...

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug Rigel Pharmaceuticals said on Tuesday it has struck a global licensing deal for Arvinas and Pfizer's recently approved breast ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The College of American Pathologists (CAP) is the premier organization of board-certified pathologists dedicated to fostering and advocating excellence in the practice of pathology and laboratory ...

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Rigel Pharmaceuticals is $54.50, with a high forecast of $81.00 and a ...

Rigel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2026 based off last year's report dates. Learn more on ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

The culmination of his related 2nd and 3rd symphonies, the entire Symphony No. 4 by Gustav Mahler is today's Midday Masterpiece.